Abel Hall, LLC

SEC CIK: 0002013339
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

FATE holding history

Fate Therapeutics Inc in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overview All 13F holders of FATE Full Q2 2026 holdings

Shares (Q2 2026): 35,872
Value: $96.9K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of FATE by Abel Hall, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	35,872	$96.9K	<0.1%	−876−2.4%	Reduced	Holders
Q1 2026	36,748	$44.1K	<0.1%	+36,748	New	Holders